162 related articles for article (PubMed ID: 9769955)
1. [p53 and hematologic malignancies].
Preudhomme C; Fenaux P
Pathol Biol (Paris); 1997 Dec; 45(10):898-908. PubMed ID: 9769955
[TBL] [Abstract][Full Text] [Related]
2. p53 gene alterations in human hematological malignancies: a review.
Soussi T; Jonveaux P
Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
[TBL] [Abstract][Full Text] [Related]
3. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
5. [P53 genes and malignant hematologic diseases].
Jonveaux P
Bull Cancer; 1993 Aug; 80(8):697-703. PubMed ID: 8204951
[TBL] [Abstract][Full Text] [Related]
6. TP53 in hematological cancer: low incidence of mutations with significant clinical relevance.
Peller S; Rotter V
Hum Mutat; 2003 Mar; 21(3):277-84. PubMed ID: 12619113
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K
Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002
[TBL] [Abstract][Full Text] [Related]
8. Pooled analysis of p53 mutations in hematological malignancies.
Prokocimer M; Unger R; Rennert HS; Rotter V; Rennert G
Hum Mutat; 1998; 12(1):4-18. PubMed ID: 9633814
[TBL] [Abstract][Full Text] [Related]
9. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
10. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
[TBL] [Abstract][Full Text] [Related]
11. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
12. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
Fuchs O; Provaznikova D; Kocova M; Kostecka A; Cvekova P; Neuwirtova R; Kobylka P; Cermak J; Brezinova J; Schwarz J; Markova J; Salaj P; Klamova H; Maaloufova J; Lemez P; Novakova L; Benesova K
Blood Cells Mol Dis; 2008; 40(3):401-5. PubMed ID: 18182175
[TBL] [Abstract][Full Text] [Related]
13. Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia.
Ohyashiki JH; Ohyashiki K; Aizawa S; Kawakubo K; Shimamoto T; Iwama H; Hayashi S; Toyama K
Clin Cancer Res; 1996 Sep; 2(9):1583-9. PubMed ID: 9816337
[TBL] [Abstract][Full Text] [Related]
14. Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin's lymphoma.
Osada M; Ishioka C; Ichinohasama R; Kadowaki I; Murakawa Y; Watanabe M; Kanamaru R; Ikawa S
Anticancer Drug Des; 1999 Apr; 14(2):107-14. PubMed ID: 10405637
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies.
Chen Y; Takita J; Hiwatari M; Igarashi T; Hanada R; Kikuchi A; Hongo T; Taki T; Ogasawara M; Shimada A; Hayashi Y
Genes Chromosomes Cancer; 2006 Jun; 45(6):583-91. PubMed ID: 16518851
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer.
Leonard DG; Travis LB; Addya K; Dores GM; Holowaty EJ; Bergfeldt K; Malkin D; Kohler BA; Lynch CF; Wiklund T; Stovall M; Hall P; Pukkala E; Slater DJ; Felix CA
Clin Cancer Res; 2002 May; 8(5):973-85. PubMed ID: 12006509
[TBL] [Abstract][Full Text] [Related]
17. Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.
Møller MB; Gerdes AM; Skjødt K; Mortensen LS; Pedersen NT
Clin Cancer Res; 1999 May; 5(5):1085-91. PubMed ID: 10353742
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
19. Role of epigenetic changes in hematological malignancies.
Lehmann U; Brakensiek K; Kreipe H
Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between p53 gene and chromosome 13q14 variations and prognosis in primary intestinal lymphoma].
Feng LJ; Zhang GP; Xie M; Cao PF; Fu CY; Hu ZL; Dai M
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):555-8. PubMed ID: 19650989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
